SCHEMBL7322017

SCHEMBL7322017

Cn1cccc1-c1nc2cc(Cl)cc(CCc3ccccn3)c2o1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.36
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
HSD17B10 Q99714 2/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
BRD4 O60885 1/20 0.32
CREBBP Q92793 1/20 0.32
MKNK1 Q9BUB5 1/20 0.32
MKNK2 Q9HBH9 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7322971 0.80 NPC1 (0.41) KDM4EALDH1A1NPC1RAB9AHSD17B10
SCHEMBL7325292 0.79 KDM4E (0.34) HSP90AA1KDM4EALDH1A1NPC1RAB9A
SCHEMBL7315804 0.78 ALDH1A1 (0.36) HSP90AA1KDM4EALDH1A1NPC1RAB9A
SCHEMBL7325321 0.78 ADORA2A (0.49) KDM4EALDH1A1NPC1RAB9AHSD17B10
SCHEMBL7323231 0.78 ALDH1A1 (0.43) KDM4EALDH1A1NPC1RAB9AHSD17B10
SCHEMBL7326452 0.78 HRH4 (0.44) HSP90AA1KDM4EALDH1A1NPC1RAB9A
SCHEMBL7322773 0.78 CYP2D6 (0.36) HSP90AA1KDM4EALDH1A1NPC1RAB9A
SCHEMBL7317091 0.77 PDGFRB (0.38) HSP90AA1KDM4EALDH1A1NPC1RAB9A
SCHEMBL7324311 0.77 KDM4E (0.40) HSP90AA1KDM4EALDH1A1NPC1RAB9A
SCHEMBL7315751 0.77 RAB9A (0.43) KDM4EALDH1A1NPC1RAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166041-A 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma EURO-CELTIQUE, S.A. (LU) 2000-12-26 US claimed
US-6166041-A 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma EURO-CELTIQUE, S.A. (LU) 2000-12-26 US disclosed